Fertility drugs and ovarian cancer

被引:13
|
作者
Artini, PG
Fasciani, A
Cela, V
Battaglia, C
deMicheroux, AA
DAmbrogio, G
Genazzani, AR
机构
[1] Dept. of Obstetrics and Gynecology, Center for Assisted Reproduction, University of Pisa, Pisa
[2] Dept. of Obstetrics and Gynecology, University of Modena, Modena
[3] Dept. of Obstetrics and Gynecology, Center for Assisted Reproduction, University of Pisa, 56100 Pisa
关键词
infertility; fertility treatment; ovarian cancer; epidemiology;
D O I
10.3109/09513599709152318
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent case reports of ovarian cancer associated with infertility treatment raise the question of a possible etiopathogenetic role of fertility drugs in ovarian cancer. In this paper, the possible relationship between infertility treatment and ovarian cancer is reviewed with respect to the epidemiological and pathogenetic profiles of ovarian cancer and the potential risk factors associated with fertility drugs; a case report review and a critical reappraisal are also provided within this article. Currently available data in the literature, from epidemiological studies and case reports, suggest that a direct causal effect of infertility treatment on ovarian cancer seems unlikely. Since infertile women are likely to have a higher risk for the development of ovarian cancer, and the role of fertility drugs in the etiopathogenesis of ovarian carcinoma is not established, a close clinical examination of infertile patients before, during and after infertility treatment is recommended. Moreover, further investigation is required to resolve the question of the possible association between fertility drugs and ovarian cancer through large prospective epidemiological or retrospective case-control studies.
引用
收藏
页码:59 / 68
页数:10
相关论文
共 50 条
  • [41] Fertility drugs and breast cancer risk
    Lo Russo, G.
    Tomao, F.
    Spinelli, G. P.
    Prete, A. A.
    Stati, V.
    Panici, P. Benedetti
    Papa, A.
    Tomao, S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2015, 36 (02) : 107 - 113
  • [42] Fertility drugs not linked to cancer risk
    Tanday, Sanjay
    LANCET ONCOLOGY, 2014, 15 (09): : E367 - E367
  • [43] Fertility drugs and the risk of breast cancer
    Ricci, E
    Parazzini, F
    Negri, E
    Marsico, S
    La Vecchia, C
    HUMAN REPRODUCTION, 1999, 14 (06) : 1653 - 1655
  • [44] New Drugs in Ovarian Cancer
    Fleming, Gini F.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (04) : 223 - 225
  • [45] Antiangiogenic drugs in ovarian cancer
    G C Kumaran
    G C Jayson
    A R Clamp
    British Journal of Cancer, 2009, 100 : 1 - 7
  • [46] Antiangiogenic drugs in ovarian cancer
    Kumaran, G. C.
    Jayson, G. C.
    Clamp, A. R.
    BRITISH JOURNAL OF CANCER, 2009, 100 (01) : 1 - 7
  • [47] Emerging drugs for ovarian cancer
    Lorusso, Domenica
    Pietragalla, Antonella
    Mainenti, Sara
    Di Legge, Alessia
    Amadio, Giulia
    Scambia, Giovanni
    EXPERT OPINION ON EMERGING DRUGS, 2010, 15 (04) : 635 - 652
  • [48] Antiangiogenic drugs in ovarian cancer
    Markman, Maurie
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (14) : 2269 - 2277
  • [49] Emerging drugs for ovarian cancer
    Sugiyama, Toru
    Konishi, Ikuo
    EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (03) : 523 - 536